Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.2 | 0.0 |
| Revenue growth | | | | | -100.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.4 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.2 | 0.0 |
| Gross margin | | | | | | -100.0% | |
| Research and development | 42.5 | 27.9 | 17.9 | 15.6 | 7.8 | | 0.7 |
| General and administrative | 77.7 | 40.4 | 15.1 | 6.5 | 4.2 | 1.6 | 0.4 |
| EBIT | -145.2 | -68.3 | -33.0 | -22.1 | -11.9 | -4.8 | -1.1 |
| EBIT margin | | | | | | -148.8% | |
| Pre-tax income | -140.0 | -69.6 | -32.2 | -19.1 | -10.9 | -7.9 | -1.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -140.0 | -69.6 | -32.2 | -19.1 | -10.9 | -7.9 | -1.2 |
| Net margin | | | | | | -246.9% | |
| |
| Diluted EPS | ($5.49) | ($3.13) | ($1.71) | ($1.20) | ($0.97) | ($1.48) | ($1.31) |
| Shares outstanding (diluted) | 25.5 | 22.2 | 18.8 | 15.9 | 11.2 | 5.4 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|